Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea · Delayed Price · Currency is KRW 1,302.00
-16.00 (-1.21%)
Jan 29, 2026, 3:30 PM KST
Enzychem Lifesciences Market Cap
Enzychem Lifesciences has a market cap or net worth of 102.32 billion as of January 29, 2026. Its market cap has decreased by -10.06% in one year.
Market Cap
102.32B
Enterprise Value
-2.63B
Revenue
72.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,302.00
Market Cap Chart
Since April 5, 2017, Enzychem Lifesciences's market cap has decreased from 217.47B to 102.32B, a decrease of -52.95%. That is a compound annual growth rate of -8.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 102.32B | -13.86% |
| Dec 30, 2025 | 118.78B | 4.40% |
| Dec 30, 2024 | 113.77B | -26.43% |
| Dec 28, 2023 | 154.65B | 10.86% |
| Dec 29, 2022 | 139.50B | -69.50% |
| Dec 30, 2021 | 457.39B | -47.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whan In Pharm | 166.41B |
| Ilsung Is | 151.92B |
| SAMSUNG PHARM. Co., LTD. | 151.44B |
| Kyongbo Pharmaceutical | 145.83B |
| HANDOK | 145.37B |
| Ildong Holdings | 139.80B |
| Jeil Pharma Holdings | 123.12B |
| CKD Bio | 117.95B |